Severe pediatric adenoviral pneumonia combined with invasive pulmonary aspergillosis

Shuihua Huang1, Shengxin Zhang2, Lin Yuan3

  • 1Department of Infection, Xiamen Children's Hospital, Xiamen Branch of Fudan University Pediatric Hospital, Xiamen, Fujian, China.

Insights

Severe pediatric adenoviral pneumonia combined with invasive pulmonary aspergillosis presents with prolonged fever and cough. Risk factors include immune disorders and prior treatments, with potentially poor long-term outcomes.

Area of Science:

  • Pediatric Infectious Diseases
  • Pulmonology
  • Mycology

Background:

  • Severe pediatric adenoviral pneumonia is a significant respiratory illness in children.
  • Invasive pulmonary aspergillosis (IPA) is a serious fungal infection that can complicate viral pneumonias.
  • Co-infection of adenoviral pneumonia with IPA poses unique clinical challenges.

Purpose of the Study:

  • To analyze the clinical characteristics of severe pediatric adenoviral pneumonia.
  • To investigate the concurrent invasive pulmonary aspergillosis in these cases.
  • To identify risk factors and outcomes associated with this dual diagnosis.

Main Methods:

  • Retrospective analysis of clinical data from five pediatric patients.
  • Inclusion criteria: severe adenoviral pneumonia with confirmed invasive pulmonary aspergillosis.
  • Data collected: clinical presentation, imaging, microbiological findings, treatment, and outcomes.

Main Results:

  • Five children (1 boy, 4 girls) aged 8 months to 2 years presented with prolonged fever (11-35 days) and cough.
  • Pulmonary imaging showed opacification, effusion, emphysema, and cavities. Adenovirus and Aspergillus were detected in respiratory samples.
  • Bronchoscopy revealed mucosal damage. Treatment involved broad-spectrum antimicrobials, antifungals (voriconazole), and supportive care. Four patients were discharged; long-term follow-up indicated complications like obliterative bronchiolitis and bronchiectasis.

Conclusions:

  • Immune dysfunction and prior treatments (antibiotics, steroids) for adenovirus infection are risk factors for secondary IPA in children.
  • Diagnosis requires specific evaluation, including bronchoscopy and alveolar lavage fluid culture, due to non-specific symptoms.
  • The long-term prognosis for severe pediatric adenoviral pneumonia with IPA is potentially poor, highlighting the need for early detection and management.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
289
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
295
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
373
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
296
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
239
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
256